Gwenn Hansen - Chief Scientific Officer at Nurix Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
NRIX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Gwenn Hansen - trading volume in the past year for Nurix Therapeutics, Inc.

Holdings reported by Gwenn Hansen for Nurix Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 69K $829K $12.01 Jul 30, 2025 Direct
Restricted Stock Units 31.4K $702K $20.48 Jul 30, 2025 Direct Common Stock
Employee Stock Option (right to buy) 75K Feb 11, 2025 Direct Common Stock

Transactions reported by Gwenn Hansen for Nurix Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.